Your session is about to expire
← Back to Search
Med Wise Rx Program for Medication Management in Older Adults
N/A
Recruiting
Led By Beth Martin, PhD, MS, RPh, FAPhA
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks post-intervention (up to 12 weeks on study), 6 months post-intervention (up to 9 months on study for cohorts enrolled prior to spring 2024)
Awards & highlights
Study Summary
This trial will test an online program to help older adults manage their meds better. 160 seniors taking 4+ meds will be studied for up to 9 months.
Who is the study for?
This trial is for older adults, specifically those aged 65 and above who use at least four medications regularly. Participants must be able to speak and read English, have the cognitive ability to engage with the program, and be capable of using a computer. They should also live in their own community homes.Check my eligibility
What is being tested?
The Med Wise Rx program is being tested in this study. It's an online initiative designed to improve communication skills among seniors so they can better manage their medications by effectively accessing information and services related to their medication needs.See study design
What are the potential side effects?
Since Med Wise Rx is an educational intervention focused on improving communication skills rather than a medical treatment, it does not have traditional side effects like drugs do. However, participants may experience frustration or fatigue from learning new technology.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks post-intervention (up to 12 weeks on study), 6 months post-intervention (up to 9 months on study for cohorts enrolled prior to spring 2024)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks post-intervention (up to 12 weeks on study), 6 months post-intervention (up to 9 months on study for cohorts enrolled prior to spring 2024)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Communication Confidence measured by validated Participant Survey
Change in Knowledge about what a pharmacist can do to help as measured by Participant Survey
Change in Number of Participant Reported CMRs
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Med Wise RxExperimental Treatment1 Intervention
An evidence-informed two-session interactive behavioral workshop. Participants will begin intervention within 3 weeks of enrollment.
Group II: Waitlist ControlActive Control1 Intervention
Participants will be crossed over to Med Wise Rx intervention up to 2 months after enrollment.
Find a Location
Who is running the clinical trial?
University of Wisconsin, MadisonLead Sponsor
1,189 Previous Clinical Trials
3,169,386 Total Patients Enrolled
Beth Martin, PhD, MS, RPh, FAPhAPrincipal InvestigatorUniversity of Wisconsin, Madison
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 65 years old.I am mentally capable of participating.I take less than 4 medications regularly.I did not pass a test that checks for thinking problems.I am 65 years old or older.I cannot attend any of the Med Wise sessions.I use four or more medications.
Research Study Groups:
This trial has the following groups:- Group 1: Med Wise Rx
- Group 2: Waitlist Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available positions for participants in this research?
"From the information on clinicaltrials.gov, it can be concluded that this medical trial is not recruiting patients currently. It was initially posted on March 1st 2023 and has had no updates since then. Fortunately, there are four other studies open for enrollment presently."
Answered by AI
Are there numerous sites in Canada administering this research?
"Currently, this medical trial is being conducted at 5 separate sites. These locations include Eau Claire, Greendale and Kenosha among others. If you are interested in enrolling, it may be prudent to pick a centre that is close by so travel demands can be reduced."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger